Actionable data for marijuana business owners
Australia’s medical cannabis industry continues to experience brisk growth in patients and sales, and experts say the market could even surpass Canada’s medical sector this year.
The high cost of medical cannabis poses major obstacles for Canadian patients, even as recreational marijuana prices remain low, a new survey of thousands of Canadians suggests
News of widespread layoffs at cannabis companies across the United States have dominated headlines, but an analysis of employee head counts at America’s largest cannabis companies show several actually grew their payrolls last year.
The total U.S. economic impact generated by marijuana sales is expected to top $100 billion in 2023, up more than 12% from last year, according to a fresh analysis from the newly published MJBiz Factbook.
Germany imported a record amount of marijuana for medical and scientific use in 2022, according to new data from the country’s Federal Institute for Drugs and Medical Devices.
Canada’s cannabis consumers spent 4.52 billion Canadian dollars ($3.35 billion) on regulated adult-use products in 2022, growing 17.9% over 2021’s sales total, according to new retail sales data released Tuesday by Statistics Canada.
Canada’s regulated medical cannabis market has dwindled significantly from its peak, declining well before recreational marijuana legalization in October 2018 and continuing that downward trend as adult-use sales displaced purchases through regulated medical channels.
